Exploiting T cell receptor genes for cancer immunotherapy.
about
Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapiesGeneration of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer.Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.The construction of chimeric T-Cell receptor with spacer base of modeling study of VHH and MUC1 interaction.Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.Antigen-specific cellular immunotherapy of leukemia.Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability.Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML.A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferSubtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease.Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.Direct and indirect antitumor effects by human peripheral blood lymphocytes expressing both chimeric immune receptor and interleukin-2 in ovarian cancer xenograft model.
P2860
Q27027243-246AB486-D8BE-4840-A36F-D412AC44F408Q34506910-27D7FBF5-EC24-41D2-B0A4-8E46FDB2670AQ34727843-B3F11FF1-730A-4FB0-BAC7-036787BFC4BDQ35176505-94C8ABE0-D2E8-476B-AED5-608653970B52Q35855247-7D874F8E-0A63-4B70-880D-D48F349212A4Q36240201-7CE7116B-748C-4950-816A-81EF3305A465Q36286127-D6A4F972-70B6-4B19-B55E-8497DFDBA562Q36350996-584B27DD-DDD7-458E-866A-473ED2B10EEBQ36392957-AE5EB3B8-4B3B-4678-AE36-524BAD5CD821Q37190431-54557498-B088-4336-8F67-A842E9CAD9EEQ37417622-FAB83519-E934-4EB9-82A9-4521C47DBECFQ38003477-08EA6D76-08E9-4886-836C-6F65304EB040Q38852674-CD1764FF-3C52-4F42-B426-443B7A8FE287Q38983814-29331C56-28FB-4611-8574-0A07F14CA008Q45882718-B489C4B1-1E54-4E74-985B-F42F38E2272BQ50035982-EC44DF4D-4212-4E3C-AAA6-D1FA59C6A0E2Q54667188-D8BE8E04-CFC9-452F-A268-BB584753E251
P2860
Exploiting T cell receptor genes for cancer immunotherapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Exploiting T cell receptor genes for cancer immunotherapy.
@ast
Exploiting T cell receptor genes for cancer immunotherapy.
@en
type
label
Exploiting T cell receptor genes for cancer immunotherapy.
@ast
Exploiting T cell receptor genes for cancer immunotherapy.
@en
prefLabel
Exploiting T cell receptor genes for cancer immunotherapy.
@ast
Exploiting T cell receptor genes for cancer immunotherapy.
@en
P2093
P2860
P1476
Exploiting T cell receptor genes for cancer immunotherapy.
@en
P2093
A Tsallios
H J Stauss
R Gillmore
P2860
P304
P356
10.1111/J.1365-2249.2005.02715.X
P577
2005-02-01T00:00:00Z